Business Description
Marvel Biosciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA57384M1077
Description
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | -7.95 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -0.74 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -25.3 | |||||
3-Year EPS without NRI Growth Rate | -27.4 | |||||
3-Year FCF Growth Rate | -26 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 86.54 | |||||
9-Day RSI | 58.77 | |||||
14-Day RSI | 45.53 | |||||
6-1 Month Momentum % | 45.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.22 | |||||
Quick Ratio | 0.22 | |||||
Cash Ratio | 0.14 | |||||
Days Payable | 478.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.9 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -310.78 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.32 | |||||
EV-to-EBITDA | -2.32 | |||||
EV-to-FCF | -4.4 | |||||
Earnings Yield (Greenblatt) % | -43.1 | |||||
FCF Yield % | -27.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MBCOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marvel Biosciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.044 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 45.53 | ||
14-Day ATR ($) | 0.001207 | ||
20-Day SMA ($) | 0.078103 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.0377 - 0.14 | ||
Shares Outstanding (Mil) | 39.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Marvel Biosciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Marvel Biosciences Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Marvel Biosciences Corp Frequently Asked Questions
What is Marvel Biosciences Corp(MBCOF)'s stock price today?
The current price of MBCOF is $0.08. The 52 week high of MBCOF is $0.14 and 52 week low is $0.04.
When is next earnings date of Marvel Biosciences Corp(MBCOF)?
The next earnings date of Marvel Biosciences Corp(MBCOF) is .
Does Marvel Biosciences Corp(MBCOF) pay dividends? If so, how much?
Marvel Biosciences Corp(MBCOF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |